ANIMATION

Bavituximab Mechanism of Action (MOA)

Share this animation:

Together with Peregrine, we helped depict the mechanism of action behind Bavituximab, an investigational treatment that helps the body recognize cancer cells. Upregulated expression of phosphatidylserine by cancer cells contributes to their ability to avoid destruction by the immune system. Bavituximab targets phosphatidylserine, thereby encouraging active immune activity in cancerous environments.

Share It:
Contact XVIVO

Client


Peregrine Pharmaceuticals, Inc.

XVIVO was asked to create an extremely complex but biochemically and biologically accurate animation that depicted the role of neuropeptides in brain plasticity. The final product was astounding — far beyond our expectations. This animation is now being used to educate breast cancer survivors on how cognitive processes are restored after chemotherapy. I would highly recommend XVIVO to others seeking similar products.

Lyn Freeman, Ph.D., CEO, Mind Matters Research, LLC
Share this animation: